Abstract
Tumor immune surveillance and CD8+ T cells in particular appear capable of recognizing the antigenic properties of human tumor cells. However, those antigen specific T cells are often excluded from tumor tissue or are functionally limited in their cytotoxic capacity. Instead, the immune response provides proinflammatory cytokines and proteases promoting tumor growth and progression while subverting cytotoxic anti-tumor immunity. The cytokines and the inflammatory mechanisms driving tumor associated inflammation resemble tissue remodeling processes during wound healing and chronic inflammatory diseases. In this chapter, we summarize the current knowledge of how inflammatory cytokines may promote the deviation of anti-tumor immunity toward a tumor promoting, noncytotoxic inflammation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) J Biol Chem 278:1910–1914
Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H (2006) Ann N Y Acad Sci 1091:151–169
Atkins MB, Robertson MJ, Gordon M, Lotze MT, DeCoste M, DuBois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML (1997) Clin Cancer Res 3:409–417
Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF (2000) Nat Med 6:583–588
Baffet G, Braciak TA, Fletcher RG, Gauldie J, Fey GH, Northemann W (1991) Mol Biol Med 8:141–156
Balkwill F, Charles KA, Mantovani A (2005) Cancer Cell 7:211–217
Becker C, Fantini MC, Schramm C, Lehr HA, Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Galle PR, Blessing M, Rose-John S, Neurath MF (2004) Immunity 21:491–501
Bending D, De La Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, Cooke A (2009) J Clin Invest 119:565–572
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006) Nature 441:235–238
Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J (1992) Nature 360:258–261
Cebon J, Jager E, Shackleton MJ, Gibbs P, Davis ID, Hopkins W, Gibbs S, Chen Q, Karbach J, Jackson H, MacGregor DP, Sturrock S, Vaughan H, Maraskovsky E, Neumann A, Hoffman E, Sherman ML, Knuth A (2003) Cancer Immun 3:7
Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB, Gorman DM, Smith K, de Waal Malefyt R, Kastelein RA, McClanahan TK, Bowman EP (2006) J Exp Med 203(12):2577–2587
Christopher MJ, Link DC (2007) Curr Opin Hematol 14:3–8
Coussens LM, Werb Z (2002) Nature 420:860–867
Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Nature 421:744–748
Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Nat Med 10:942–949
Elzey BD, Griffith TS, Herndon JM, Barreiro R, Tschopp J, Ferguson TA (2001) J Immunol 167:3049–3056
Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A (2009) J Clin Invest 119:3573–3585
Feldmann M, Maini RN (2001) Annu Rev Immunol 19:163–196
Fonseca C, Dranoff G (2008) Clin Cancer Res 14:1603–1608
Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S (1998) Int Rev Immunol 16:541–551
Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pages F (2006) Science 313:1960–1964
Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, Consolaro MR, De Marchi M, Giachino D, Robbiano A, Astegiano M, Sambataro A, Kastelein RA, Carra G, Trinchieri G (2008) J Exp Med 205:1447–1461
Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, Beckhove P, Gounari F, Khazaie K (2009) Cancer Res 69:5490–5497
Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, Becher B, Waisman A (2009) J Clin Invest 119:61–69
Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK (2008) Clin Cancer Res 14:3372–3379
Happel KI, Dubin PJ, Zheng M, Ghilardi N, Lockhart C, Quinton LJ, Odden AR, Shellito JE, Bagby GJ, Nelson S, Kolls JK (2005) J Exp Med 202:761–769
He D, Wu L, Kim HK, Li H, Elmets CA, Xu H (2006) J Immunol 177:6852–6858
Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL (2008) Science 321:408–411
Jager E, Jager D, Knuth A (2003) Int J Cancer 106:817–820
Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD (1998) Proc Natl Acad Sci USA 95:7556–7561
Knuth A, Danowski B, Oettgen HF, Old LJ (1984) Proc Natl Acad Sci USA 81:3511–3515
Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD (2007) Nature 450:903–907
Koehne CH, Dubois RN (2004) Semin Oncol 31:12–21
Kolls JK, Linden A (2004) Immunity 21:467–476
Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W (2007) J Immunol 178:6730–6733
Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, Chang A, Coukos G, Liu R, Zou W (2009a) Blood 114:1141–1149
Kryczek I, Wei S, Szeliga W, Vatan L, Zou W (2009b) Blood 114:357–359
Kwong BY, Roberts SJ, Silberzahn T, Filler RB, Neustadter JH, Galan A, Reddy S, Lin WM, Ellis PD, Langford CF, Hayday AC and Girardi M (2009) J Invest Dermatol Doi: 10.1038/jid.2009.362
LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S, Korneluk RG (2008) Oncogene 27:6252–6275
Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F (2003) Cancer Res 63:3560–3566
Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M (2006) Nature 442:461–465
Langowski JL, Kastelein RA, Oft M (2007) Trends Immunol 28:207–212
Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) J Exp Med 201:233–240
Lejeune FJ, Ruegg C, Lienard D (1998) Curr Opin Immunol 10:573–580
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Annu Rev Immunol 24:99–146
Lin WW, Karin M (2007) J Clin Invest 117:1175–1183
Liu SJ, Tsai JP, Shen CR, Sher YP, Hsieh CL, Yeh YC, Chou AH, Chang SR, Hsiao KN, Yu FW, Chen HW (2007) J Leukoc Biol 82:354–360
Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang BL, Lee CN, Wu CW, Tao MH (2003) J Immunol 171:600–607
Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ (2007) CA Cancer J Clin 57:225–241
Lockhart E, Green AM, Flynn JL (2006) J Immunol 177:4662–4669
Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006) Nature 441:231–234
Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, Hwu P, Restifo NP, Overwijk WW, Dong C (2009) Immunity 31:787–798
McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ (2007) Nat Immunol 8:1390–1397
McKenzie BS, Kastelein RA, Cua DJ (2006) Trends Immunol 27:17–23
Mocellin S, Rossi CR, Pilati P, Nitti D (2005) Cytokine Growth Factor Rev 16:35–53
Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Nat Med 5:828–831
Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K, Gattinoni L, Wrzesinski C, Hinrichs CS, Kerstann K, Feigenbaum L, Chan CC, Restifo NP (2008) Blood 112(2):362–373
Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) Cancer Res 58:3491–3494
Naugler WE, Karin M (2008) Trends Mol Med 14:109–119
Novelli F, Casanova JL (2004) Cytokine Growth Factor Rev 15:367–377
Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT (2003) Blood 101:2620–2627
Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J (2005) Proc Natl Acad Sci USA 102:3372–3377
Reiner SL (2007) Cell 129:33–36
Roberts SJ, Ng BY, Filler RB, Lewis J, Glusac EJ, Hayday AC, Tigelaar RE, Girardi M (2007) Proc Natl Acad Sci USA 104:6770–6775
Rose-John S, Scheller J, Elson G, Jones SA (2006) J Leukoc Biol 80:227–236
Ruegg C, Oguey D, Lejeune F (1999) Melanoma Res 9:2–3
Scott KA, Moore RJ, Arnott CH, East N, Thompson RG, Scallon BJ, Shealy DJ, Balkwill FR (2003) Mol Cancer Ther 2:445–451
Seliger B, Cabrera T, Garrido F, Ferrone S (2002) Semin Cancer Biol 12:3–13
Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET (2001) Cytokine Growth Factor Rev 12:33–40
Szlosarek PW, Balkwill FR (2003) Lancet Oncol 4:565–573
Szlosarek P, Charles KA, Balkwill FR (2006) Eur J Cancer 42:745–750
Trinchieri G, Pflanz S, Kastelein RA (2003) Immunity 19:641–644
Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cua DJ, Powrie F (2006) Immunity 25:309–318
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) Science 254:1643–1647
Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T (2002) Immunol Rev 188:51–64
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) Immunity 24:179–189
Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H (2009) J Exp Med 206:1457–1464
Williams RO, Marinova-Mutafchieva L, Feldmann M, Maini RN (2000) J Immunol 165:7240–7245
Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DJ, McClanahan TK (2007) Bowman EP and de Waal Malefyt R. Nat Immunol 8:950–957
Wong GH, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW (1984) Nature 310:688–691
Wrzesinski SH, Wan YY, Flavell RA (2007) Clin Cancer Res 13:5262–5270
Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C (2008) Immunity 29:44–56
Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, Kleinschek MA, Owyang A, Mattson J, Blumenschein W, Murphy E, Sathe M, Cua DJ, Kastelein RA, Rennick D (2006) J Clin Invest 116:1310–1316
Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, Goldberg MV, Liang KL, Bruno TC, Pyle KJ, Chan SL, Anders RA, Trimble CL, Adler AJ, Lin TY, Pardoll DM, Huang CT, Drake CG (2009) J Immunol 183:7161–7168
Zhou LJ, Tedder TF (1996) Proc Natl Acad Sci USA 93:2588–2592
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mumm, J.B., Oft, M. (2010). Subversion and Coercion: The Art of Redirecting Tumor Immune Surveillance. In: Dranoff, G. (eds) Cancer Immunology and Immunotherapy. Current Topics in Microbiology and Immunology, vol 344. Springer, Berlin, Heidelberg. https://doi.org/10.1007/82_2010_47
Download citation
DOI: https://doi.org/10.1007/82_2010_47
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-14135-5
Online ISBN: 978-3-642-14136-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)